news_6

Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer

ONTRUZANT® is Samsung Bioepis’ first oncology biosimilar available in the United States INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. announced today...

news_6

Outlook on the Male Grooming Products Market in India to 2024 – Increased Penetration of Social Media Platforms is Helping to Drive the Market – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Male Grooming Products Market in India 2019" report has been added to ResearchAndMarkets.com's offering. The male grooming market...